EIF4EBP1 and pancreatic neoplasm: In fact, treatment with the SOCE inhibitor RP4010 in pancreatic cancer led to reduced NFAT translocation and increased expression of eukaryotic translation initiation factor 4E-binding protein 1 (EIF4EBP1) [154].